Posts

Showing posts from February, 2026

Patent and Patent Information Events in February 2026 (Part 2 Feb. 16-28, 2026)

Image
 Patent and Patent Information Events in February 2026 (Part 2 Feb. 16-28, 2026)  The post below is a copy of the post published on Feb. 14, 2026 (updated Feb.16, 2026) at the PIUG Community Discussion Forum .     Summary: 2/17 WIPO Launch of the WIPR 2026; Deep IP  Source-Backed AI Answers ; Ankar AI Chemistry Drafting Process; 2/18 USPTO Hour Central Reexamination Unit ; 2/19 WIPO CWS/NSTF/2026/1; Wilson Gunn Patenting cosmetics; SLW Institute AI-Driven Innovation in MedTech: Patent Eligibility; 2/24-26 WIPO IPC/CE/57; 2/24 Questel Basic Training Orbit Intelligence; Questel GenAI for advanced patent and TM workflows; Patsnap Integrating Litigation in R&D risk analysis; Questel Orbit Intelligence – [AI] Sophia Document: Use cases and Prompting ) ; D Young & Co. European Biotech Patent Case Law; 2/25 WIPO CWS/SEQLTF/2026/1; EPO search tools for business decisions; COHAUSZ & FLORACK EPO Case Law Update 2025/2026 Engineering, physics and ...

Patent and Patent Information Events in February 2026 (Part 1: Feb. 2-13, 2026)

 Patent and Patent Information Events in February 2026 (Part 1: Feb. 2-13, 2026)  (Updated 2/9/2024) The post below is a copy of the post published on Feb. 1, 2026 (updated Feb.9, 2026) at the PIUG Community Discussion Forum .   Summary 2/2-5 EPO Search and Examination Matters 2026 ; PCT CTC/33; 2/6 PCT/WG/19; 2/2 EPO AI Tools for the Future 2/3  WIPO Standard Essentiality Verification in Patentscope ; EPO Prior art search with Ansera /Standards; E PO Pre-search; PIUG QPIP Exam Prep Course (+2/4); LexisNexis   5G Patent Leaders and the Road to 6G  (+2/4); CAS IP Finder™ Tips and Tricks (+2/4); 2/4 EPO GUI + AI; EPO AI in Bioinformatics; 2/4-6 INPIT Beginners’ Patent information utilization training; 2/5 EPO The Legal Interactive Platform; Judicial decisions around AI and patents; Sterne Kessler  2025 PTAB Year in Review; 2/6 EPO/I3PM  IP strategy bootcamp (2/17 & 3/2); 2/10-11 USPTO [Novelty Assesment];  2/9 EU IP ...